Bungarus multicinctus venom toxins (BmVT)

Bungarus multicinctus venom toxins are a complex mixture of highly potent neuroproteins derived from the many-banded krait, a medically significant elapid snake in East Asia. The venom's pathophysiology is primarily driven by two toxin families: three-finger toxins (3FTxs), such as alpha-bungarotoxin, and phospholipases A2 (PLA2), such as beta-bungarotoxin. Alpha-bungarotoxin acts post-synaptically by binding with extreme high affinity and near-irreversibility to nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction, effectively blocking motor signaling. In contrast, beta-bungarotoxin targets the pre-synaptic terminal, where its enzymatic activity causes the depletion of synaptic vesicles and prevents the release of acetylcholine. Clinical envenomation typically results in progressive neuromuscular paralysis and life-threatening respiratory failure, often without significant local pain or swelling at the bite site. Therapeutic intervention relies on the administration of specific antivenoms to neutralize circulating toxins; however, once toxins are bound to their physiological targets, they are difficult to displace, necessitating rapid treatment and often prolonged mechanical ventilation.

Other names

Many-banded krait venomBungarotoxinsBmVTBungarus multicinctus neurotoxins

Specific antivenom antibodies bind directly to the circulating venom proteins (neutralization), preventing them from interacting with their physiological targets such as post-synaptic nicotinic acetylcholine receptors and pre-synaptic nerve terminals. This passive immunity facilitates the clearance of toxins from the bloodstream.